Home » Topics » BioWorld Science

BioWorld Science
RSS

Alpha Cognition reports preclinical data from ALPHA-1062 intranasal TBI program

Dec. 7, 2021

Spago completes regulatory preclinical program with Tumorad

Dec. 7, 2021

Kaleido and Janssen expand Microbiome Metabolic Therapies collaboration

Dec. 7, 2021

Gb Sciences develops cannabinoid-containing complex mixtures to target CRS in COVID-19

Dec. 7, 2021

Gritstone and CEPI expand agreement for SAM vaccine to target SARS-CoV-2 Omicron variant

Dec. 7, 2021

Phylex develops SARS-CoV-2 vaccine targeting Delta and Omicron variants

Dec. 7, 2021

Incyte describes new mutant GTPase KRAS inhibitors

Dec. 7, 2021

Jiangsu Simcere Pharmaceutical R&D discovers SERDs

Dec. 7, 2021

New ACSS2 inhibitors discovered at Metabomed

Dec. 7, 2021

Shanghai Litedd presents new nuclear receptor RORgammaT antagonists

Dec. 7, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 1, 2026.
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
New evidence links autoimmunity to long COVID symptoms
BioWorld
Recent findings are reshaping current understanding of the post-infection landscape of SARS-CoV-2. Although previous studies had already suggested that...
Breakthrough as GSK’s bepirovirsen clears 19% of chronic hep B infections
BioWorld
GSK plc has announced a breakthrough in the treatment of chronic hepatitis B, reporting a functional cure rate of 19% across two phase III trials of its antisense...
BMS’ mezigdomide doubles PFS in multiple myeloma
BioWorld
Bristol Myers Squibb Co. disclosed in March 2026 that the phase III portion of the seamless phase II/III Successor-2 study testing mezigdomide in combination with...